Acadia Pharmaceuticals (ACAD) EBT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 9,460.35% |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | -85.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.61% |
| Dec 31, 2025 | -83.67% |
| Sep 30, 2025 | 14.94% |
| Jun 30, 2025 | 8.06% |
| Mar 31, 2025 | 32.38% |
| Dec 31, 2024 | 306.10% |
| Sep 30, 2024 | 174.47% |
| Jun 30, 2024 | 486.47% |
| Mar 31, 2024 | 146.73% |
| Dec 31, 2023 | 197.11% |
| Sep 30, 2023 | -97.35% |
| Jun 30, 2023 | 118.90% |
| Mar 31, 2023 | 60.08% |
| Dec 31, 2022 | 4.80% |
| Sep 30, 2022 | -78.51% |
| Jun 30, 2022 | 22.65% |
| Mar 31, 2022 | -69.47% |
| Dec 31, 2021 | 35.33% |
| Sep 30, 2021 | 82.57% |
| Jun 30, 2021 | -3.95% |
| Mar 31, 2021 | 24.53% |
| Dec 31, 2020 | -26.04% |
| Sep 30, 2020 | -100.89% |
| Jun 30, 2020 | 23.50% |
| Mar 31, 2020 | -3.64% |
| Dec 31, 2019 | 19.61% |
| Sep 30, 2019 | 31.61% |
| Jun 30, 2019 | 13.44% |
| Mar 31, 2019 | -58.30% |
| Dec 31, 2018 | 4.97% |
| Sep 30, 2018 | 4.37% |
| Jun 30, 2018 | 5.96% |
| Mar 31, 2018 | 38.87% |
| Dec 31, 2017 | 10.93% |
| Sep 30, 2017 | 9.82% |
| Jun 30, 2017 | 6.00% |
| Mar 31, 2017 | -76.36% |
| Dec 31, 2016 | -222.09% |
| Sep 30, 2016 | -84.07% |
| Jun 30, 2016 | -81.12% |
| Mar 31, 2016 | -23.25% |
| Dec 31, 2015 | 89.57% |
| Sep 30, 2015 | -56.97% |
| Jun 30, 2015 | -83.20% |
| Mar 31, 2015 | -126.47% |
| Dec 31, 2014 | 150.43% |
| Sep 30, 2014 | -131.75% |
| Jun 30, 2014 | -136.70% |
| Mar 31, 2014 | -191.16% |
| Dec 31, 2013 | 295.98% |
| Sep 30, 2013 | -345.25% |
| Jun 30, 2013 | -67.58% |
| Mar 31, 2013 | 1.53% |
| Dec 31, 2012 | -28.49% |
| Sep 30, 2012 | 52.68% |
| Jun 30, 2012 | 17.34% |
| Mar 31, 2012 | -6.60% |
| Dec 31, 2011 | -118.19% |
| Sep 30, 2011 | -20.09% |